Keep Your Eyes on This Stock: Scholar Rock Holding Corporation (NASDAQ: SRRK)

On 08 May 2020, Scholar Rock Holding Corporation (NASDAQ: SRRK) spotted trading -30.54% off 52-week high price. On the other end, the stock has been noted 127.77% away from the low price over the last 52-weeks. The stock changed 1.60% to recent value of $15.83. The stock transacted 75703 shares during most recent day however it has an average volume of 98.9K shares. The company has 32.56M of outstanding shares and 25.53M shares were floated in the market.

Scholar Rock (SRRK) recently stated financial results for the full year ended December 31, 2019 and highlighted recent progress and upcoming milestones for its pipeline programs.

Full Year 2019 Financial Results

For the year ended December 31, 2019, net loss was $51.0M or $1.85 per share contrast to a net loss of $49.3M or $3.15 per share for the year ended December 31, 2018.

  • Revenue was $20.5M for the year ended December 31, 2019 and was related to the Gilead Alliance Contract that was executed in December 2018.
  • Research and development expense was $54.2M for the year ended December 31, 2019 contrast to $36.3M for the year ended December 31, 2018. The increase year-over-year primarily reflects preclinical and manufacturing costs for SRK-181 and higher personnel-related costs, slightly offset by lower manufacturing costs for SRK-015 and early development costs.
  • General and administrative expense was $20.8M for the year ended December 31, 2019 contrast to $14.4M for the year ended December 31, 2018. The increase year-over-year was primarily attributable to increased headcount and professional services.

As of December 31, 2019, Scholar Rock had cash, cash equivalents, and marketable securities of $157.4M, contrast to $175.6M as of December 31, 2018. A $25M payment was received in January 2020 from Gilead for the achievement of the preclinical milestone under the planned fibrosis-focused collaboration.

The price moved ahead of -3.74% from the mean of 20 days, 3.75% from mean of 50 days SMA and performed 32.38% from mean of 200 days price. Company’s performance for the week was 5.25%, 4.49% for month and YTD performance remained 20.11%.

 

Leave a Reply

Your email address will not be published. Required fields are marked *